|
 |
Enterix launches lab-based InSure FIT test
 |
|
| Enterix, a wholly-owned subsidiary of Quest Diagnostics and US-based biotechnology company announced the availability of the InSure Quik F I T fecal immunochemical test, a point-of-care version of the company's lab-based InSure FIT |
|
 |
|
|
| |
|
|
| |
| Ocimum Biosolutions launches Genowiz 4.0
|
|
| Ocimum Biosolutions, a leading provider of integrated genomics solutions headquartered in Hyderabad in India has announced the release of Genowiz 4.0, a comprehensive solution for gene expression analysis. The latest version makes the process simpler |
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| Ranbaxy launches Bonista to treat osteoporosis
|
|
| Ranbaxy Laboratories, India's largest pharmaceutical company, has launched Bonista - Teriparatide injection (recombinant human parathyroid hormone) for the treatment of Osteoporosis, in collaboration with Virchow Biotech |
|
|
|
|
| |
|
|
| |
| Sequenom sells MassARRAY systems in China
|
|
| Sequenom, a major provider of fine mapping genotyping, methylation and gene expression analysis solutions, has announced the sales of multiple MassARRAY systems in China |
|
|
|
|
| More |
